This list is an analysis based on recent market events. It's not an investment recommendation.
About
Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.
The current price of CTS.AU is A$0.92 AUD — it has decreased by -3.68% in the past 24 hours. Watch Ceretas stock price performance more closely on the chart.
What is Ceretas stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Ceretas stocks are traded under the ticker CTS.AU.
What is Ceretas market cap?▼
Today Ceretas has the market capitalization of 35.11M